MariaTeresaAbreuMD

Inflammatory Bowel Disease

Professor of Medicine, University Miami School of Medicine

Dr. Abreu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1011 NW 15th St
Gautier 501 (D-149)
Miami, FL 33136
Phone+1 305-243-6404

Fax+1 305-243-6125

Dr. Maria T. Abreu is an IBD expert at the University of Miami Miller School of Medicine. Patient care takes place at the Crohn's and Colitis Clinic at the University of Miami Sylvester Cancer Center. She received her medical degree from University of Miami Miller School of Medicine and has been in practice 27 years. She performs basic and translational research. Her area of interest is innate immune signaling, therapeutic drug monitoring, and the genetics of IBD, esp in Hispanic patients.

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1992 - 1995
Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1992
University of Miami Leonard M. Miller School of MedicineClass of 1990

The Sherman Prize The Bruce and Cynthia Sherman Charitable Foundation, 2019
Elected Member, Association of American Physicians 2018
America's Top Doctors Castle Connolly, 2008-2014
Top Doctors:South Florida Castle Connolly, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Fellow (AGAF) American Gastroenterological Association, 2011
Elected Member The American Society for Clinical Investigation, 2010
Top Doctors: New York Metro Area Castle Connolly, 2007-2008
Super Doctor SuperDoctors.com
Join now to see all

PubMed

368 citations
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Bruce E Sands, William J Sandborn, Remo Panaccione, Christopher D O'Brien, Hongyan Zhang
The New England Journal of Medicine. 2019-09-26
113 citations
A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci
Eimear E. Kenny, Itsik Pe'er, Amir Karban, Laurie J. Ozelius, Adele A. Mitchell
Plos Genetics. 2012-03-08
42 citations
Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.
Clara Abraham, Maria T Abreu, Jerrold R Turner
Gastroenterology. 2022-05-01

Cedars-Sinai Taps New Director of F. Widjaja Inflammatory Bowel Disease InstituteNovember 11th, 2024
Gastroenterologists Question Benefits, Note Potential Harms of New UHC ProgramOctober 21st, 2024
The ABCs of Optimizing Drug Sequencing for IBDOctober 15th, 2024
Join now to see all

Role Of TLR4 In Colitis-Associated NeoplasiaNational Cancer Institute2009–2012
Toll- LIKE Receptor-Complex In Intestinal Epithelial CellsNational Institute Of Allergy And Infectious Diseases2008–2009
Toll-Like Receptor-Complex In Intestinal Epith. CellsNational Institute Of Allergy And Infectious Diseases2004–2007
Role Of TLR4 In Acute And Chronic Murine ColitisNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
Randomized, Double-Masked, Placebo-Controlled Pilot TRNational Center For Research Resources2004
Toll-Like Receptor-Complex In Intestinal Epith. CellsNational Institute Of Allergy And Infectious Diseases2003–2004
Protection From Fas-Mediated Apoptosis In The GutNational Institute Of Diabetes And Digestive And Kidney Diseases2002
Toll-Like Receptor-Complex In Intestinal CellsNational Institute Of Allergy And Infectious Diseases2002
Growth And Death Signals In The ProstateNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002